Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 2 Study of AMG 785 in Postmenopausal Women With Low Bone Mineral Density
This study is ongoing, but not recruiting participants.
Study NCT00896532   Information provided by Amgen

First Received on May 7, 2009.   Last Updated on April 16, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Low Bone Mineral Density
Postmenopausal Osteoporosis
Additional conditions recognized in this trial
Osteoporosis
Osteoporosis, Postmenopausal
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Musculoskeletal Diseases
Interventions listed in this trial
Active Comparator Alendronate
Placebo
AMG 785
Active comparator teriparatide
Denosumab
Additional drug interventions recognized in this trial
Alendronate
Teriparatide
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services